Education
About Us
Working with TipRanks
Follow Us
Mural Oncology Plc (MURA)
NASDAQ:MURA
Total Valuation
Mural Oncology Plc has a market cap or net worth of $45.76M. The enterprise value is ―.
Market Cap$45.76M
Enterprise Value―
Share Statistics
Mural Oncology Plc has 17,268,880 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding17,268,880
Owned by Insiders3.39%
Owned by Institutions33.91%
Financial Efficiency
Mural Oncology Plc’s return on equity (ROE) is -0.91 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)-0.91
Return on Assets (ROA)-0.76
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee0.00
Profits Per Employee-1.11M
Employee Count116
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Mural Oncology Plc is -0.42. Mural Oncology Plc’s PEG ratio is -0.03.
PE Ratio-0.42
PS Ratio0.00
PB Ratio0.47
Price to Fair Value0.39
Price to FCF-0.52
Price to Operating Cash Flow-0.52
PEG Ratio-0.03
Income Statement
In the last 12 months, Mural Oncology Plc had revenue of 0.00 and earned -128.51M in profits. Earnings per share was -7.58.
Revenue0.00
Gross Profit0.00
Operating Income0.00
Pretax Income-128.51M
Net Income-128.51M
EBITDA0.00
Earnings Per Share (EPS)-7.58
Cash Flow
In the last 12 months, operating cash flow was -128.54M and capital expenditures -92.00K, giving a free cash flow of -128.64M billion.
Operating Cash Flow-128.54M
Free Cash Flow-128.64M
Free Cash Flow per Share-7.45
Dividends & Yields
Mural Oncology Plc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.27
52-Week Price Change-29.71%
50-Day Moving Average2.48
200-Day Moving Average3.28
Relative Strength Index (RSI)56.68
Average Volume (3m)9.52M
Important Dates
Mural Oncology Plc upcoming earnings date is May 20, 2025, TBA Not Confirmed.
Last Earnings DateMar 11, 2025
Next Earnings DateMay 20, 2025
Ex-Dividend Date―
Financial Position
Mural Oncology Plc as a current ratio of 5.84, with Debt / Equity ratio of 5.71%
Current Ratio5.84
Quick Ratio5.84
Debt to Market Cap0.15
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Mural Oncology Plc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Mural Oncology Plc EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.41.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow0.41
EV to Operating Cash Flow0.41
Balance Sheet
Mural Oncology Plc has $144.38M in cash and marketable securities with $8.02M in debt, giving a net cash position of -$136.36M billion.
Cash & Marketable Securities$144.38M
Total Debt$8.02M
Net Cash-$136.36M
Net Cash Per Share-$7.90
Tangible Book Value Per Share$8.29
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Mural Oncology Plc is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.00
Price Target Upside126.42% Upside
Analyst ConsensusModerate Buy
Analyst Count4
Revenue Growth Forecast―
EPS Growth Forecast―